The mathematics of health improvement also factor into cost analysis
The results were dose-dependent and dramatic
The dose of OA was selected based on our previous work in pancreatic cells and isolated smooth muscle cells (Kumar et al., 2013)
Mounjaro is a dual agonist , meaning it activates two receptors: GLP1 receptor GIP receptor The UK SmPC also lays out how dosing usually works (start low and increase slowly): starting dose 2.5 mg once weekly, then move to 5 mg, then step up in 2.5 mg increments if needed (with at least 4 weeks at each step)
Each succeeding iteration surpassed their predecessors in effectiveness: Mounjaro trumped Ozempic, and now Eli Lilly just published trial results showing subjects on the highest dose of their investigational triple-action drug rituratide lost an average of 24% of their body weight over 48 weeks
Preclinical studies have shown that balanced activation of these receptors avoids the hyperglycemic risk associated with glucagon monotherapy while preserving its lipolytic benefits [19]